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Abstract: Leptin-deficient ob/ob mice are resis-
tant to dextran sulfate sodium (DSS)-induced coli-
tis and Concanavalin A (Con A)-induced hepatitis.
However, the signal transduction pathways in-
volved have not been identified. The present study
investigated the effect of leptin-induced STAT3 sig-
naling in the DSS and Con A models. Mice carrying
a leptin receptor (LEPR) gene mutant for Y1138
(s/s mice), with abrogated leptin-induced STAT3
signaling, were compared with wild-type (WT) and
LEPR-deficient db/db mice. Administration of DSS
to s/s mice resulted in a clinical score and colon
shortening of intermediate severity compared with
disease induced in WT and db/db mice—the latter
group having the lowest disease severity. A compa-
rable degree of inflammatory infiltrate and epithe-
lial damage was observed in the colon of WT and s/s
mice, and these parameters were reduced in db/db
mice. Levels of IFN-, IL-6, IL-10, and TNF-
were comparable in the colon of s/s and db/db
mice, and a similar trend was observed for CXCL2.
s/s and WT mice developed severe liver disease in
response to Con A, whereas db/db mice were pro-
tected. However, Con A-induced serum IL-6 and
TNF- levels in s/s mice mimicked levels observed
in db/db rather than WT mice. In conclusion, lack
of leptin-induced STAT3 signaling is associated
with reduced cytokine production following DSS
and Con A administration, but it appears to sensi-
tize mice to the effects of proinflammatory
mediators. J. Leukoc. Biol. 85: 491–496; 2009.
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INTRODUCTION
Leptin is produced and secreted predominantly by adipocytes
and is therefore classified as an adipokine [1]. Most well known
for its control of appetite, leptin is also involved in the regu-
lation of metabolic, endocrine, and immune functions [1, 2].
The importance of leptin in maintaining cellularity and func-
tion of the immune system has been characterized extensively,
particularly in models of autoimmunity and inflammation [3, 4].
Leptin exerts its effects by binding to the long form of the
leptin receptor (LEPR), the only isoform that is capable of
intracellular signaling through activation of tyrosine residues
[5]. Having structural and functional similarities with members
of the long-chain helical cytokines, such as IL-6 and IL-12,
leptin is considered a proinflammatory cytokine, and its recep-
tor is related to class I cytokine receptors, the common signal-
transducing component for the IL-6-related family of cytokines
[2, 6, 7]. Activation of LEPR results in autophosphorylation of
Janus kinase (JAK) 2, which leads to phosphorylation of ty-
rosine residues 985, 1077, and 1138 in LEPR. When acti-
vated, each of the three tyrosine phosphorylation sites recruits
specific downstream signaling proteins, which mediate leptin’s
signaling [3, 8]. P-Y985 recruits tyrosine phosphatase Src
homology 2 domain-containing tyrosine phosphatase 2 (SHP-
2), which induces ERK1/2 [3, 9]. In addition, suppressor of
cytokine signaling (SOCS) 3 binds to P-Y985, contributing to
attenuation of LEPR signaling [10, 11]. P-Y1077 contributes to
downstream signaling through transcriptional activation of sig-
nal transducer and activator of transcription (STAT) 5 [10].
P-Y1138 recruits STAT3, a cytokine-regulated transcription
factor involved in immune function, resulting in its phosphor-
ylation and nuclear translocation [8].
In addition to being obese, leptin (ob/ob)- and LEPR (db/
db)-deficient mice have alterations in immune and inflamma-
tory responses [12]. In particular, ob/ob mice exhibit reduced
disease severity in the experimental model of intestinal inflam-
mation induced by dextran sulfate sodium (DSS) and in Con-
canavalin A (Con A)-induced autoimmune hepatitis [13, 14].
However, the signal transduction pathways associating lack of
leptin to protection in these two different models are not fully
understood. In an attempt to clarify these mechanisms, we used
knock-in mice that have a mutation in the Y1138 residue of
LEPR (s/s mice), which disrupts leptin-induced STAT3 signal-
ing but allows leptin to signal through Y985 and Y1077
effectively [15]. Similar to db/db mice, s/s mice are hyperphagic
and develop early- onset obesity with hepatic steatosis, sec-
ondary to lack of STAT3-mediated leptin signaling in hypotha-
lamic neurons [15].
To evaluate the involvement of leptin-mediated STAT3 sig-
naling in regulating inflammation, we compared the response of
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s/s mice with that of their lean wild-type (WT) littermates and
of db/db mice, which are completely unable to signal through




Care of mice followed institutional guidelines under a protocol approved by the
Institutional Animal Care and Use Committee at the University of Illinois at
Chicago (Chicago, IL, USA). All mice used in these experiments were on a
C57BL6 background. s/s mice were generated as described previously [15].
Ten-week-old male and female s/s mice and their lean WT littermates fed a
regular chow were used for the experiments. Mice were genotyped by real-time
PCR using specific primers [8] and the TaqMan system (Applied Biosystems,
Foster City, CA, USA). Age- and sex- matched db/db mice were obtained from
The Jackson Laboratory (Bar Harbor, ME, USA). As reported previously, s/s
and db/db mice were markedly obese as a result of severe hyperphagia, secondary
to lack of STAT3-mediated leptin signaling in the hypothalamus [15].
Induction and evaluation of colitis
Mice were given 3% DSS (MW 40 kDa; MP Biochemicals, Solon, OH, USA),
dissolved in drinking water ad libitum for 5 days, followed by 5 days of normal
drinking water, resulting in a 10-day experimental period [13]. Control mice
were given normal drinking water without DSS. A clinical score (0–12)
described previously, which takes into account body weight loss, diarrhea, and
blood in the stools, was assessed daily to quantify clinical disease [16].
Postmortem, the entire colon was excised from the cecum to the anus, and
colon length was recorded as a marker of inflammation [17]. A 0.05- to 1-cm
segment of the transverse colon was fixed in 10% buffered formalin overnight
for histological analysis. Paraffin sections (5 m) were stained with H&E. A
histological score, consisting of inflammatory cell infiltrate (0–3) and epithelial
damage (0–3), was evaluated in a blinded manner by a pathologist as de-
scribed previously [18].
Cytokine and chemokine measurement in DSS-
induced colitis
Duplicate segments of the transverse colon were excised, cut longitudinally,
and washed in PBS containing 1% penicillin and streptomycin. The pieces of
colon were placed in 24-well culture plates containing 1 ml RPMI with 1%
penicillin and streptomycin and incubated at 37°C for 24 h. Colon culture
supernatants were then harvested and assayed for cytokines and chemokines
by ELISA kits from BD Bioscience (San Jose, CA, USA) and eBioscience (San
Diego, CA, USA). Protein concentration of the supernatant was quantified
using the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA, USA).
Cytokine expression was measured in the colon by real-time RT-PCR using
specific primers for IFN-, IL-6, IL-10, TNF-, and CXCL2 and the TaqMan
system (Applied Bioscience).
Induction of hepatitis
Con A (Sigma Chemical Co., St. Louis, MO, USA) was reconstituted in
pyrogen-free PBS at 2 mg/ml. Mice were injected i.v. in the tail vein with 200
g Con A. Control mice received an equal amount of PBS. Blood was obtained
from the retro-orbital plexus at 1.5 h and 24 h after Con A administration, and
serum was prepared. Serum levels of alanine aminotransferase (ALT) were
determined using a colorimetric endpoint method (TECO Diagnostics, Ana-
heim, CA, USA). Serum levels of TNF- and IL-6 were measured using ELISA
kits from eBioscience. A histological score was blindly calculated on liver
sections as follows: 0–3 for inflammatory infiltrate; 0–3 for extent of necrosis;
0–3 for extent of steatosis; and 0  no involvement; 1  mild; 2  moderate;
and 3  severe for each of the three parameters.
Statistical analysis
Statistical significance was determined by ANOVA using Fisher’s least sig-
nificant difference. Error bars represent the SEM (SEM). Statistical analyses
were performed using XLStat software (Addinsoft, Brooklyn, NY, USA). Dif-
ferences were considered significant for P  0.05.
RESULTS
DSS-induced colitis in s/s mice
To investigate whether leptin-induced STAT3 signaling regu-
lates colonic inflammation, we compared the response of s/s
mice with that of their WT littermates and of LEPR-deficient
db/db mice in the DSS model of colitis. Throughout the 10-day
experiment, a clinical score was calculated to quantify disease
severity by weight loss, diarrhea, and blood in stools. Begin-
ning on Day 3 of DSS administration, WT and s/s mice started
to show signs of disease activity (Fig. 1). Similar to data
reported previously, obtained in ob/ob mice [13], db/db mice
started to show minor signs of disease on Day 4 and began
recovery after Day 5. The clinical score of db/db mice was
significantly lower compared with that of WT mice beginning
on Day 5 and throughout the remaining experiment. The clin-
ical score of s/s mice was intermediate between that of WT and
db/db mice and is significantly lower than the score of WT mice
beginning on Day 5 but significantly higher than that of db/db
mice beginning on Day 6 until completion of the experiment on
Day 10 (Fig. 1).
Colon shortening is a typical sign of inflammation in DSS-
induced colitis and correlates with disease severity [17]. DSS-
treated WT mice exhibited a 28.9% reduction in colon length,
and colon shortening in db/db mice was only 1.3%, similar to
data obtained previously in ob/ob mice [13]. A 13.8% reduction
in colon length was observed in DSS-treated s/s mice (Table
1), confirming the intermediate phenotype of these mice.
However, a different pattern was observed when histological
analysis of colon sections was performed (Fig. 2). In fact, at
the end of the 10-day DSS experiment, s/s mice had a histo-
logical score comparable with that of WT mice, whereas a
significantly lower score—in terms of inflammatory infiltrate
Fig. 1. Disease activity score in WT, s/s, and db/db mice receiving DSS. WT
(), s/s (shaded e), and db/db (‚) mice received DSS from Day 1 until Day 5.
Disease activity score was calculated daily as described in Materials and
Methods. Beginning on Day 5 and until Day 10, disease score in s/s mice was
significantly lower than in WT mice (P0.05 at each day). Beginning on Day
6 and until Day 10, disease score in s/s mice was significantly higher compared
with db/db mice (P0.05 at each day). Beginning on Day 5 and until Day 10,
disease score in db/db mice was significantly lower than in WT mice (P0.05
at each day). Data are mean  SEM; n  6–9 mice per group.
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and epithelial damage—was present in db/db mice, in agree-
ment with previous data obtained in ob/ob mice [13].
Cytokine levels in DSS-induced colitis in s/s mice
We have demonstrated previously a role for leptin in regulating
colonic cytokine expression in the DSS model using ob/ob mice
[13]. The effect of leptin-induced STAT3 signaling on cytokine
production by colonic tissue after DSS was evaluated. Colon
segments from each mouse were cultured overnight, and the
spontaneous release of IFN-, IL-6, IL-10, TNF-, and CXCL2
was determined by analyzing supernatants (Fig. 3). The total
colon culture system was used to allow the evaluation of
cytokines produced spontaneously by the entire intestine under
inflammatory conditions [13]. As observed previously in ob/ob
mice [13], db/db mice produced significantly lower levels of
Fig. 3. Cytokine and chemokine production by colon cultures in WT, s/s, and
db/db mice receiving DSS. WT (black bars), s/s (gray bars), and db/db (white
bars) mice received DSS from Day 1 until Day 5. At Day 10, mice were killed,
and colon cultures were performed. Production of IFN-, IL-6, IL-10, TNF-,
and CXCL2 was measured by ELISA in culture supernatants. Data are mean 
SEM; n  6–9 mice per group. ***, P  0.001; **, P  0.01.
TABLE 1. DSS-Induced Colon Shortening in WT, s/s, and
db/db Mice
Mice Water DSS
WT 6.9  0.19 4.9  0.12a
s/s 7.2  0.25 6.2  0.22b,c
db/db 7.6  0.29 7.5  0.26c,d
Mice received regular drinking water or DSS as detailed in Materials and
Methods. On Day 10, colons were removed, and their length was measured
(cm). a P  0.001 versus respective water; b P  0.05; c P  0.001 versus
WT DSS; d P  0.01 versus s/s DSS.
Fig. 2. Histological analysis in WT, s/s, and db/db mice receiving DSS. (A)
Histological score of WT (black bars), s/s (gray bars), and db/db (white bars)
mice received DSS from Day 1 until Day 5. At Day 10, mice were killed, and
the colon was obtained for histological analysis. (B) H&E staining in the colon
of WT control mice and in the colon of WT, s/s, and db/db mice that received
treatment with DSS. Data are mean  SEM; n  6–9 mice per group. *, P 
0.05; ***, P  0.001.
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IFN-, IL-6, IL-10, TNF-, and CXCL2 compared with WT
mice when given DSS. Cytokine release from colonic tissue of
s/s mice was not significantly different from that of db/db mice,
with the sole exception of CXCL2, which, however, followed a
similar trend as the other cytokines (Fig. 3).
Expression of IFN-, IL-6, IL-10, TNF-, and CXCL2
mRNA was measured by real-time RT-PCR and is displayed in
Table 2. Expression of IFN-, IL-6, and TNF- in the colon
of db/db and s/s mice was significantly lower compared with
WT colons, in agreement with that observed at the protein
level. A similar trend was observed for IL-10 and CXCL2,
although for these two cytokines, the difference did not reach
statistical significance. Whereas at the protein level, IL-6 and
TNF- were comparable in the colon of s/s and db/db mice,
mRNA expression of these cytokines was significantly lower in
db/db mice compared with s/s mice. Thus, leptin-induced
STAT3 signaling appears to be important for cytokine produc-
tion in response to DSS.
Con A-induced hepatitis in s/s mice
Previous reports have shown that leptin deficiency protects
mice from Con A-induced hepatitis [7, 14]. To evaluate
whether leptin-induced STAT3 signaling is involved in the
decreased response of ob/ob mice to Con A, we induced hep-
atitis by injecting Con A in s/s, WT, and db/db mice. As
anticipated based on previous data obtained in ob/ob mice [7,
14], serum ALT levels in WT mice were significantly higher
(65%) compared with db/db mice at 24 h after Con A, the peak
elevation time of serum ALT in this model [19, 20] (Fig. 4).
Serum ALT levels in s/s mice were not significantly different
from those of WT mice and were significantly higher compared
with db/db mice. In agreement with ALT data, histological
analysis of liver sections indicated a significantly lower necro-
sis score in db/db compared with WT and s/s mice injected with
Con A (Fig. 5, B and D). However, a similar degree of
inflammatory infiltrate was observed in all groups (Fig. 5, A
and D). As a result of lack of leptin signaling in the brain of
db/db mice and consequent massive obesity with insulin resis-
tance, a high degree of hepatic steatosis is present in these
animals compared with lean mice [21]. A similar degree of
hepatic steatosis was present in vehicle-injected s/s and db/db
mice, which are both obese compared with lean WT mice (Fig.
5, C and D). The extent of steatosis was reduced in s/s mice
after Con A treatment but remained high in the db/db mice. We
have shown previously that leptin deficiency, rather than obe-
sity, is responsible for protection in Con A-induced hepatitis
[14]. The present data thus suggest that leptin-induced STAT3
signaling is not the mechanism linking leptin deficiency to
protection in the Con A-induced model.
Cytokine levels in Con A-induced hepatitis in
s/s mice
db/db and s/s mice had significantly lower systemic levels of
IL-6 and TNF- compared with WT mice at 1.5 h post-Con A
(Fig. 6A). In all three groups, TNF- levels returned to
baseline at 24 h, whereas IL-6 levels were still elevated in WT
mice compared with s/s and db/db mice at 24 h (Fig. 6B).
Levels of IFN- followed a similar trend and were significantly
higher in WT compared with s/s and db/db mice (data not
shown). Thus, s/s mice developed severe liver damage in re-
sponse to Con A, despite producing low levels of cytokines.
DISCUSSION
We demonstrated previously that absence of leptin in ob/ob
mice is protective against development of DSS-induced intes-
tinal inflammation and Con A-induced hepatitis [13, 14]. Using
s/s mice in the present report, we investigated the role of
leptin-induced STAT3 signaling in these same models. Our
data indicate that STAT3 activation by leptin is critical for
modulation of cytokine production in response to DSS and Con
A. However, the increased disease severity of s/s mice com-
pared with db/db mice suggests that leptin-induced signaling
pathways, independent of STAT3, are involved in disease
pathogenesis in the DSS and Con A models.
Fig. 4. Serum ALT levels in WT, s/s, and db/db mice receiving Con A. WT
(black bars), s/s (gray bars), and db/db (white bars) mice received 200 g Con
A or saline. Serum ALT levels were measured 24 h after injection. Data are
mean  SEM; n  5 mice per group. **, P  0.01; ***, P  0.001.
TABLE 2. DSS-Induced mRNA Cytokine Expression in the Colon
Mice IFN- IL-6 IL-10 TNF- CXCL2
WT 46.9  35.2 288.9  5.1 1.2  0.9 2.5  0.1 16.3  5.8
s/s 0.2  0.08a 255.0  3.7b 0.9  0.3 2.1  0.1c 6.9  3.8
db/db 1.0  0.56a 0.0  0.0b,d 0.1  0.1 1.5  0.0b,e 3.9  1.9
Mice received DSS as detailed in Materials and Methods. mRNA was extracted from a snap-frozen colon taken at Day 10 and analyzed for the expression of
IFN-, IL-6, IL-10, TNF-, and CXCL2. Data are expressed as fold induction compared with control WT mice that did not receive DSS. a P  0.01; b P  0.001;
c P  0.05 versus WT DSS; d P  0.001, e P  0.01 versus s/s DSS.
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Although signaling through STAT3 mediates leptin’s effects
on food intake, hepatic glucose production, and gonadotropin
secretion [22], control of adipose tissue lipogenesis and arterial
neointima formation by leptin is STAT3-independent [23, 24].
The present report indicates that regulation of IFN-, IL-6,
IL-10, and TNF- by leptin in response to DSS and Con A is
mediated largely by the STAT3 pathway, as levels of these
cytokines in s/s mice were comparable with those observed in
db/db mice. mRNA expression of IFN-, IL-6, and TNF- in
the colon was also lower in s/s compared with WT and thus,
appears to be regulated, at least in part, by leptin-induced
STAT3 signaling. Release of CXCL2, as well as expression of
CXCL2 and IL-10, followed this trend as well.
Despite reduced production of cytokines that are known to
mediate disease pathogenesis in the DSS and Con A models,
severity of disease in s/s mice was significantly higher than in
db/db mice in both models. In fact, both colonic and hepatic
histological scores were comparable between WT and s/s mice
and significantly lower in db/db mice in response to DSS or Con
A. Furthermore, disease activity score and colon shortening in
response to DSS as well as serum ALT levels in response to
Con A were significantly higher in s/s compared with db/db
mice. These observations, coupled with data indicating re-
duced cytokine production in s/s mice, suggest that the lack of
leptin’s induced STAT3 signaling sensitizes mice to the dele-
terious effects of proinflammatory mediators. The STAT3 path-
way is one of the major signaling pathways involved in trans-
lating cytokine signals into gene expression programs regulat-
ing proliferation and differentiation of immune cells [25]. The
critical role of STAT3 signaling in alleviating inflammation is
demonstrated by the outcome of selective deficiency of STAT3
in immune or endothelial cells, which leads to increased
sensitivity to endotoxin challenge and development of sponta-
Fig. 5. Histological analysis in WT, s/s, and db/db mice receiving Con A. WT
(black bars), s/s (gray bars), and db/db (white bars) mice received 200 g Con
A or saline. At 24 h, mice were killed, and the liver was obtained for
histological analysis. (A) Inflammatory infiltrate; (B) necrosis; (C) steatosis; (D)
H&E staining in the liver of WT, s/s, and db/db mice before (Control) and after
treatment with Con A. Data are mean  SEM; n  5 mice per group. *, P 
0.05; **, P  0.01; ***, P  0.001.
Fig. 6. Serum cytokine levels in WT, s/s, and db/db mice receiving Con A.
WT (black bars), s/s (gray bars), and db/db (white bars) mice received 200 g
Con A or saline. (A) Serum TNF- and IL-6 levels measured 1.5 h after
injection. (B) Serum TNF- and IL-6 levels measured 24 h after injection. Data
are mean  SEM; n  5 mice per group. **, P  0.01; ***, P  0.001.
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neous colitis in mice [26–28]. The STAT3 pathway is also
critical in mediating the hepatic anti-inflammatory response in
the model of Con A-induced hepatitis [29].
Among other targets, leptin-induced STAT3 phopshorylation
induces transcription of SOCS3, which attenuates overall lep-
tin signaling [30]. Lack of this negative, SOCS3-mediated
feedback inhibition in s/s mice likely leads to prolonged LEPR
stimulation through Y985 and Y1077, providing a possible
explanation for increased sensitivity to the pathological effects
of inflammatory mediators after DSS and Con A administration.
Because of the general anti-inflammatory nature of STAT3-
activated responses [31], it is likely that lack of leptin-induced
STAT3 signaling may lead to overactivation of the PI-3K and
MAPK pathways, known to mediate some of the proinflamma-
tory activities of leptin [32].
In conclusion, data presented in this report indicate that
leptin-induced STAT3 signaling is largely involved in regulat-
ing cytokine production by leptin in response to DSS and Con
A. However, leptin-induced STAT3 signaling does not appear
to be essential in disease pathogenesis of DSS-induced colitis
or Con A- induced hepatitis and appears to sensitize mice to
the deleterious effects of proinflammatory mediators.
ACKNOWLEDGMENTS
This work was supported by National Institutes of Health grant
DK061483 (to G. F.). The authors have no conflicts of interest
to disclose.
REFERENCES
1. Fantuzzi, G. (2005) Adipose tissue, adipokines, and inflammation. J.
Allergy Clin. Immunol. 115, 911–919.
2. Tilg, H., Moschen, A. R. (2006) Adipocytokines: mediators linking adi-
pose tissue, inflammation and immunity. Nat. Rev. Immunol. 6, 772–783.
3. Hekerman, P., Zeidler, J., Korfmacher, S., Bamberg-Lemper, S., Knobel-
spies, H., Zabeau, L., Tavernier, J., Becker, W. (2007) Leptin induces
inflammation-related genes in RINm5F insulinoma cells. BMC Mol. Biol.
8, 41.
4. Fantuzzi, G. (2006) Leptin: nourishment for the immune system. Eur.
J. Immunol. 36, 3101–3104.
5. Tartaglia, L. A. (1997) The leptin receptor. J. Biol. Chem. 272, 6093–
6096.
6. Baumann, H., Morella, K. K., White, D. W., Dembski, M., Bailon, P. S.,
Kim, H., Lai, C. F., Tartaglia, L. A. (1996) The full-length leptin receptor
has signaling capabilities of interleukin 6-type cytokine receptors. Proc.
Natl. Acad. Sci. USA 93, 8374–8378.
7. Fantuzzi, G., Sennello, J. A., Batra, A., Fedke, I., Lehr, H. A., Zeitz, M.,
Siegmund, B. (2005) Defining the role of T cell-derived leptin in the
modulation of hepatic or intestinal inflammation in mice. Clin. Exp.
Immunol. 142, 31–38.
8. Banks, A. S., Davis, S. M., Bates, S. H., Myers Jr., M. G. (2000) Activation
of downstream signals by the long form of the leptin receptor. J. Biol.
Chem. 275, 14563–14572.
9. Carpenter, L. R., Farruggella, T. J., Symes, A., Karow, M. L., Yancopou-
los, G. D., Stahl, N. (1998) Enhancing leptin response by preventing
SH2-containing phosphatase 2 interaction with Ob receptor. Proc. Natl.
Acad. Sci. USA 95, 6061–6066.
10. Gong, Y., Ishida-Takahashi, R., Villanueva, E. C., Fingar, D. C., Mun-
zberg, H., Myers Jr., M. G. (2007) The long form of the leptin receptor
regulates STAT5 and ribosomal protein S6 via alternate mechanisms.
J. Biol. Chem. 282, 31019–31027.
11. Eyckerman, S., Broekaert, D., Verhee, A., Vandekerckhove, J., Tavernier,
J. (2000) Identification of the Y985 and Y1077 motifs as SOCS3 recruit-
ment sites in the murine leptin receptor. FEBS Lett. 486, 33–37.
12. Fantuzzi, G., Faggioni, R. (2000) Leptin in the regulation of immunity,
inflammation, and hematopoiesis. J. Leukoc. Biol. 68, 437–446.
13. Siegmund, B., Lehr, H. A., Fantuzzi, G. (2002) Leptin: a pivotal mediator
of intestinal inflammation in mice. Gastroenterology 122, 2011–2025.
14. Siegmund, B., Lear-Kaul, K. C., Faggioni, R., Fantuzzi, G. (2002) Leptin
deficiency, not obesity, protects mice from Con A-induced hepatitis. Eur.
J. Immunol. 32, 552–560.
15. Bates, S. H., Stearns, W. H., Dundon, T. A., Schubert, M., Tso, A. W.,
Wang, Y., Banks, A. S., Lavery, H. J., Haq, A. K., Maratos-Flier, E., Neel,
B. G., Schwartz, M. W., Myers Jr., M. G. (2003) STAT3 signaling is
required for leptin regulation of energy balance but not reproduction.
Nature 421, 856–859.
16. Siegmund, B., Sennello, J. A., Jones-Carson, J., Gamboni- Robertson, F.,
Lehr, H. A., Batra, A., Fedke, I., Zeitz, M., Fantuzzi, G. (2004) Leptin
receptor expression on T lymphocytes modulates chronic intestinal in-
flammation in mice. Gut 53, 965–972.
17. Okayasu, I., Hatakeyama, S., Yamada, M., Ohkusa, T., Inagaki, Y.,
Nakaya, R. (1990) A novel method in the induction of reliable experi-
mental acute and chronic ulcerative colitis in mice. Gastroenterology 98,
694–702.
18. Siegmund, B., Rieder, F., Albrich, S., Wolf, K., Bidlingmaier, C., Firest-
ein, G. S., Boyle, D., Lehr, H. A., Loher, F., Hartmann, G., Endres, S.,
Eigler, A. (2001) Adenosine kinase inhibitor GP515 improves experimen-
tal colitis in mice. J. Pharmacol. Exp. Ther. 296, 99–105.
19. Pini, M., Sennello, J. A., Chan, L., Fantuzzi, G. (2006) Adiponectin
deficiency does not affect the inflammatory response to endotoxin or
concanavalin A in mice. Endocrinology 147, 5019–5022.
20. Sennello, J. A., Fayad, R., Morris, A. M., Eckel, R. H., Asilmaz, E.,
Montez, J., Friedman, J. M., Dinarello, C. A., Fantuzzi, G. (2005) Regu-
lation of T cell-mediated hepatic inflammation by adiponectin and leptin.
Endocrinology 146, 2157–2164.
21. Cohen, P., Zhao, C., Cai, X., Montez, J. M., Rohani, S. C., Feinstein, P.,
Mombaerts, P., Friedman, J. M. (2001) Selective deletion of leptin recep-
tor in neurons leads to obesity. J. Clin. Invest. 108, 1113–1121.
22. Buettner, C., Pocai, A., Muse, E. D., Etgen, A. M., Myers Jr., M. G.,
Rossetti, L. (2006) Critical role of STAT3 in leptin’s metabolic actions.
Cell Metab. 4, 49–60.
23. Buettner, C., Muse, E. D., Cheng, A., Chen, L., Scherer, T., Pocai, A., Su,
K., Cheng, B., Li, X., Harvey-White, J., Schwartz, G. J., Kunos, G.,
Rossetti, L. (2008) Leptin controls adipose tissue lipogenesis via central,
STAT3-independent mechanisms. Nat. Med. 14, 667–675.
24. Bodary, P. F., Shen, Y., Ohman, M., Bahrou, K. L., Vargas, F. B., Cudney,
S. S., Wickenheiser, K. J., Myers Jr., M. G., Eitzman, D. T. (2007) Leptin
regulates neointima formation after arterial injury through mechanisms
independent of blood pressure and the leptin receptor/STAT3 signaling
pathways involved in energy balance. Arterioscler. Thromb. Vasc. Biol. 27,
70–76.
25. Pfitzner, E., Kliem, S., Baus, D., Litterst, C. M. (2004) The role of STATs
in inflammation and inflammatory diseases. Curr. Pharm. Des. 10, 2839–
2850.
26. Matsukawa, A., Takeda, K., Kudo, S., Maeda, T., Kagayama, M., Akira, S.
(2003) Aberrant inflammation and lethality to septic peritonitis in mice
lacking STAT3 in macrophages and neutrophils. J. Immunol. 171, 6198–
6205.
27. Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Forster,
I., Akira, S. (1999) Enhanced Th1 activity and development of chronic
enterocolitis in mice devoid of Stat3 in macrophages and neutrophils.
Immunity 10, 39–49.
28. Kano, A., Wolfgang, M. J., Gao, Q., Jacoby, J., Chai, G. X., Hansen, W.,
Iwamoto, Y., Pober, J. S., Flavell, R. A., Fu, X. Y. (2003) Endothelial cells
require STAT3 for protection against endotoxin-induced inflammation. J.
Exp. Med. 198, 1517–1525.
29. Radaeva, S., Sun, R., Pan, H. N., Hong, F., Gao, B. (2004) Interleukin 22
(IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22
is a survival factor for hepatocytes via STAT3 activation. Hepatology 39,
1332–1342.
30. Munzberg, H., Myers Jr., M. G. (2005) Molecular and anatomical deter-
minants of central leptin resistance. Nat. Neurosci. 8, 566–570.
31. El Kasmi, K. C., Holst, J., Coffre, M., Mielke, L., de Pauw, A., Lhocine,
N., Smith, A. M., Rutschman, R., Kaushal, D., Shen, Y., Suda, T.,
Donnelly, R. P., Myers Jr., M. G., Alexander, W., Vignali, D. A., Wa-
towich, S. S., Ernst, M., Hilton, D. J., Murray, P. J. (2006) General nature
of the STAT3- activated anti-inflammatory response. J. Immunol. 177,
7880–7888.
32. Lam, Q. L., Lu, L. (2007) Role of leptin in immunity. Cell. Mol. Immunol.
4, 1–13.
496 Journal of Leukocyte Biology Volume 85, March 2009 http://www.jleukbio.org
